Merck's late-stage KEYNOTE-355 trial met endpoint of overall survival in breast cancer study
27 Luglio 2021 - 01:53PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Grafico Azioni Merck (NYSE:MRK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Merck (NYSE:MRK)
Storico
Da Mar 2023 a Mar 2024